학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 192건 | 목록 1~20
Academic Journal
Yap TA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TYap@mdanderson.org.; Sweis RF; University of Chicago, Chicago, IL, USA.; Vaishampayan U; University of Michigan, Ann Arbor, MI, USA.; Kilari D; Medical College of Wisconsin, Milwaukee, WI, USA.; Gainor JF; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; McKean M; Sarah Cannon Research Institute, Nashville, TN, USA.; Barve M; Sarah Cannon Research Institute at Mary Crowley, Dallas, TX, USA.; Tarhini AA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Bockorny B; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Sonpavde G; AdventHealth Medical Group, Orlando, FL, USA.; Park D; St. Jude Crosson Cancer Institute/Providence Medical Foundation, Fullerton, CA, USA.; Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN, USA.; Ju Y; Scholar Rock, Inc., Cambridge, MA, USA.; Liu L; Scholar Rock, Inc., Cambridge, MA, USA.; Henry S; Scholar Rock, Inc., Cambridge, MA, USA.; Tirucherai GS; Scholar Rock, Inc., Cambridge, MA, USA.; DeWall S; Scholar Rock, Inc., Cambridge, MA, USA.; Qatanani M; Scholar Rock, Inc., Cambridge, MA, USA.; Marantz JL; Scholar Rock, Inc., Cambridge, MA, USA.; Gan L; Scholar Rock, Inc., Cambridge, MA, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Falcón A; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain. afalconglez@gmail.com.; Ponce S; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Cote GM; Mass General Cancer Center, Boston, MA, USA.; Gil A; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain.; Lin JJ; Mass General Cancer Center, Boston, MA, USA.; Bockorny B; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Martínez J; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain.; Kahatt C; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Martinez S; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Zubiaur P; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Siguero M; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Cullell-Young M; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Jiménez J; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Zugazagoitia J; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Paz-Ares L; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Universidad Complutense, Madrid, Spain.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Hammel P; Hôpital Paul Brousse, Villejuif, France.; Metges JP; Cancer and Imaging Institute CHU Cavale Blanche, Arpego Network, Brest, France.; Macarulla Mercade T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, IIS Imas12, Medicine Department, Universidad Complutense of Madrid (UCM), Madrid, Spain.; Bouché O; Department of Digestive Oncology, Université Reims Champagne Ardenne, CHU Reims, Reims, France.; Portales F; Oncologie médicale, Institut du Cancer de Montpellier, Paris, France.; Pazo Cid RA; Medical Oncology Department, Hospital Universitario Miguel Servet/Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.; Mineur L; Oncologue Radiotherapeute Unité Fonctionnelle Cancérologie Digestive, Avignon, France.; Cubillo Gracian A; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Hospital Universitario HM Sanchinarro, HM Hospitales, Spain.; Trouilloud I; Hôpital Saint-Antoine, Paris, France.; Guimbaud R; Hôpital Rangueil, Institut Universitaire du Cancer de Toulouse - Rangueil-Larrey, Toulouse, France.; Tougeron D; Hepato-Gastroenterology Department, Poitiers University Hospital, Poitiers, France.; Reina JJ; Hopital Universitario Virgen Macarena, Sevilla, Spain.; Feliu J; Department of Medical Oncology, La Paz University Hospital, IdiPAZ, CIBERONC, UAM, Madrid, Spain.; Sauri T; Medical Oncology Department, Clinic University Hospital, Translational Genomics and Targeted Therapies in Solid Tumors (IDIBAPS), Barcelona, Spain.; Fountzilas C; Roswell Park Comprehensive Cancer Center, Scott Bieler Clinical Science Center, Buffalo, NY.; Lecomte T; Hôpital Trousseau, CHRU de Tours, Tours Cedex 09, France.; Molin Y; Institut de Cancérologie de la Sauvegarde, Clinique de la Sauvegarde, Lyon, France.; Ponz-Sarvise M; Department of Medical Oncology and Program in Solid Tumors, CIMA Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Forget F; CHA, Vivalia Oncologie, Libamont, Belgium.; Berardi R; Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.; Van Cutsem E; University Hospitals Gasthuisberg & KU, Leuven, Leuven, Belgium.; Gelsomino F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.; Tournigand C; Medical Oncology, APHP, Hôpital Henri Mondor, UPEC, Creteil, France.; Bockorny B; Beth Israel Deaconess Medical Center, Dana Farber Harvard Cancer Center, Boston, MA.; Bachet JB; Sorbonne University, Department of Hepato-Gastroenterology and Digestive Oncology, Pitié Salpêtrière Hospital, APHP, Paris, France.; Marin Vera M; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Cuyle PJ; Gastroenterology and Digestive Oncology Department, Imelda General Hospital, Bonheiden, Belgium.; Wasan H; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.; Noel M; Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.; Van Laethem JL; Hopital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.; Kay R; RK Statistics Ltd, Bakewell, United Kingdom.; Youssoufian H; Department of Medicine, Brown University Health, Providence, RI.; El-Hariry I; Erytech Pharma, Lyon, France.; Ranok Therapeutics, Waltham, MA.; Hidalgo M; Weill Cornell Medicine, Hematology and Medical Oncology, New York, NY.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Publisher: Connecticut State Medical Society Country of Publication: United States NLM ID: 0372745 Publication Model: Print Cited Medium: Print ISSN: 0010-6178 (Print) Linking ISSN: 00106178 NLM ISO Abbreviation: Conn Med Subsets: MEDLINE
Academic Journal
Bockorny B; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States.; Harvard Medical School, Boston, United States.; Muthuswamy L; Blueprint Medicines, Cambridge, United States.; Huang L; Henry Ford Cancer Institute, Detroit, United States.; Hadisurya M; Department of Biochemistry, Purdue University West Lafayette, West Lafayette, United States.; Maria Lim C; Nanyang Technological University, Singapore, Singapore.; Tsai LL; Harvard Medical School, Boston, United States.; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, United States.; Gill RR; Harvard Medical School, Boston, United States.; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, United States.; Wei JL; Harvard Medical School, Boston, United States.; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, United States.; Bullock AJ; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States.; Harvard Medical School, Boston, United States.; Grossman JE; Agenus Inc, Lexington, United States.; Besaw RJ; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States.; Narasimhan S; Deciphera Pharmaceuticals, Waltham, United States.; Tao WA; Department of Biochemistry, Purdue University West Lafayette, West Lafayette, United States.; Perea S; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States.; Sawhney MS; Harvard Medical School, Boston, United States.; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, United States.; Freedman SD; Harvard Medical School, Boston, United States.; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, United States.; Hildago M; Division of Hematology-Oncology, Weill Cornell Medical College, New York, United States.; New York-Presbyterian Hospital, New York, United States.; Iliuk A; Tymora Analytical Operations, West Lafayette, United States.; Muthuswamy SK; National Cancer Institute, Bethesda, United States.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Sarno F; Hospital Universitario de Fuenlabrada, Madrid, Spain.; Tenorio J; CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; INGEMM-IdiPAZ Institute of Medical and Molecular Genetics, Madrid, Spain.; ITHACA, European Reference Network, Brussels, Belgium.; Perea S; Hospital Universitario de Fuenlabrada, Madrid, Spain.; Medina L; UGCI Medical Oncology, Hospital Regional y Virgen de la Victoria, IBIMA, Malaga, Spain.; Pazo-Cid R; Hospital Universitario Miguel Servet, Zaragoza, Spain.; Juez I; Hospital Universitario de Fuenlabrada, Madrid, Spain.; Garcia-Carbonero R; Hospital Universitario 12 de Octubre, Imas12, Facultad de Medicina UCM, Madrid, Spain.; Feliu J; Hospital Universitario La Paz, Madrid, Spain.; Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.; Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Guillen-Ponce C; Hospital Universitario Ramon y Cajal, Madrid, Spain.; Lopez-Casas PP; Instituto de Investigación Sanitaria, Hospital 12 de octubre (imas 12), Madrid, Spain.; Guerra C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Duran Y; Hospital Universitario de Fuenlabrada, Madrid, Spain.; López-Acosta JF; Hospital Universitario de Fuenlabrada, Madrid, Spain.; Alonso C; Hospital Universitario de Fuenlabrada, Madrid, Spain.; Esquivel E; Unidad de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Dopazo A; Unidad de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Akshinthala D; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; Muthuswamy SK; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; Lapunzina P; CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; INGEMM-IdiPAZ Institute of Medical and Molecular Genetics, Madrid, Spain.; ITHACA, European Reference Network, Brussels, Belgium.; Bockorny B; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Hidalgo M; Division of Hematology-Oncology, Weill Cornell Medical College, New York, New York.; New York-Presbyterian Hospital, New York, New York.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Correa TL; Beth Israel Deaconess Medical Center, Harvard Medical School, United States. Electronic address: tulioloyolacorrea@hotmail.com.; Keko M; Beth Israel Deaconess Medical Center, Harvard Medical School, United States.; Danielian P; Cleveland Clinic, Ohio, United States.; Modest AM; Beth Israel Deaconess Medical Center, Harvard Medical School, United States.; Antunes V; Porto Alegre Health Sciences Federal University, Brazil.; Costa MC; Unimed Sorocaba, Brazil.; Fernandes MV; Porto Alegre Health Sciences Federal University, Brazil.; Milioli NJ; Pontifical Catholic University of Rio Grande do Sul, Brazil.; Martins OC; Federal University of Juiz de Fora, Brazil.; Baraldo S; Department of Endoscopy, Barretos Cancer Hospital, Brazil.; Bockorny B; Beth Israel Deaconess Medical Center, Harvard Medical School, United States.
Publisher: Elsevier India Country of Publication: Switzerland NLM ID: 100966936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1424-3911 (Electronic) Linking ISSN: 14243903 NLM ISO Abbreviation: Pancreatology Subsets: MEDLINE
Academic Journal
Ko AH; Division of Hematology/Oncology, University of California San Francisco, 1825 4th Street, San Francisco, CA, 941158, USA. andrew.ko@ucsf.edu.; Coveler AL; Division of Hematology/Oncology, University of Washington Medical Center, Seattle, WA, USA.; Schlechter BL; Division of Gastrointestinal Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Bekaii-Saab T; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Wolpin BM; Division of Gastrointestinal Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Clark JW; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.; Bockorny B; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.; Lin YC; AltruBio, Inc, San Francisco, CA, USA.; Chiang E; AltruBio, Inc, San Francisco, CA, USA.; Langecker P; Caidya, Morrisville, NC, USA.; Lin SY; AltruBio, Inc, San Francisco, CA, USA.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
News
Hematology Week. February 6, 2012, p2.
Academic Journal
Johnson ML; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee.; Wolf BB; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Wang JS; Sarah Cannon Research Institute at Florida Cancer Specialists, Sarasota, Florida.; Philipovskiy A; Sarah Cannon Research Institute at Florida Cancer Specialists, Lake Mary, Florida.; Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts.; Bockorny B; Beth-Israel Deaconess Medical Center, Boston, Massachusetts.; Guo W; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Shen J; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Jen KY; Relay Therapeutics, Inc., Cambridge, Massachusetts.; LeRose M; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Hunter TL; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Padval M; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Schmidt-Kittler O; Relay Therapeutics, Inc., Cambridge, Massachusetts.; Bhatia N; Genentech, Inc., South San Francisco, California.; Dubey S; Genentech, Inc., South San Francisco, California.; Suchomel J; Genentech, Inc., South San Francisco, California.; Bendell JC; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Jauhari S; Sarah Cannon Research Institute at Florida Cancer Specialists, Lake Mary, Florida.; Eng-Wong J; Genentech, Inc., South San Francisco, California.; Lin JJ; Department of Medicine and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Huffman BM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rahma OE; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tyan K; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Li YY; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schlechter BL; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bockorny B; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Manos MP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cherniack AD; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Baginska J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mariño-Enríquez A; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kao KZ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Maloney AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ferro A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kelland S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ng K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Singh H; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Welsh EL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pfaff KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giannakis M; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Rodig SJ; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; ImmunoProfile, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.; Hodi FS; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cleary JM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Journal of Gastrointestinal Cancer. September 2014 45(3):347-352
검색 결과 제한하기
제한된 항목
[검색어] Bockorny, B.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어